Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-10-01Clinical Trial Update: A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for Patients With Genotype 1 Hepatitis C and IL28B CC Polymorphism [Phase 3]
A Phase 3 randomized trial comparing 24-week versus 48-week courses of peginterferon plus ribavirin for genotype 1 hepatitis C patients with…
-
CLINICAL_TRIALS trial_result · 2013-09-24Clinical Trial Update: A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCV [Phase 2]
This document provides an update on a Phase 2 pilot study evaluating boceprevir for genotype 6 hepatitis C infection.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Study Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL + Ribavirin Versus Peg IFN a-2b + Ribavirin in Patients With Chronic Hepatitis C, Genotype 1 or 4 [Phase 2]
A Phase 2 study comparing tolerability and viral reduction between IFN alfa-2b XL + Ribavirin and Pegylated interferon alfa-2b + Ribavirin i…
-
CLINICAL_TRIALS trial_result · 2013-09-13Clinical Trial Update: A Study of PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols [Phase 3]
Phase 3 study of Pegasys (pegylated interferon alfa-2a) with or without ribavirin in chronic hepatitis C patients who previously participate…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Silybin - Vitamin E- Phospholipids Complex Reduces Liver Fibrosis in Patients With Chronic Hepatitis C Treated With Peg-IFN-a and RBV [Phase 3]
Phase 3 trial suggests that the silybin-Vitamin E-Phospholipids complex reduces liver fibrosis in patients with chronic hepatitis C treated …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: A Study of Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials [Phase 3]
A Phase 3 clinical trial evaluating Pegasys (peginterferon alfa-2a) alone or with Copegus (ribavirin) in patients with chronic hepatitis C w…
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4) [Phase 2]
Phase 2b study results for boceprevir in patients coinfected with HIV and hepatitis C, reporting safety and efficacy data.
-
CLINICAL_TRIALS trial_result · 2013-08-29Clinical Trial Update: Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected Patients [Phase 1]
Phase 1 study evaluating a novel Ad6NSmut/MVA-NSmut therapeutic vaccine for chronic Hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-29Clinical Trial Update: A Phase 1 Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Hepatic Function and Moderate or Severe Hepatic Impairment [Phase 1]
A Phase 1 pharmacokinetics study evaluated how normal, moderate, and severe hepatic impairment affects exposure to velpatasvir (GS-5816) in …
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 Infection [Phase 2]
A Phase 2 dose-ranging trial assessed PF-00868554 in combination with Pegasys and Copegus for chronic hepatitis C genotype 1; results from t…
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: HCV Treatment With Fluvastatin, Simvastatin to Improve Interferon Sensitivity [Phase 1]
A Phase 1 trial testing whether adding fluvastatin and simvastatin to interferon can improve interferon sensitivity in chronic hepatitis C w…
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV Patients [Phase 2]
Phase 2 trial evaluating TG4040 therapeutic vaccine in combination with pegylated interferon and ribavirin shows efficacy signals in chronic…
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C [Phase 1]
Phase 1 study evaluating GS-9620 in treatment-naive subjects with chronic hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: Characterization of Clonal B Cell Populations in HCV Infection
A completed clinical trial characterized clonal B cell populations in Hepatitis C infection to understand immune features associated with ch…
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: Hepatitis C Virus and the Humoral Immune System
A completed clinical trial update examining the interaction between Hepatitis C virus and the humoral immune system.
-
CLINICAL_TRIALS trial_result · 2013-08-08Clinical Trial Update: Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients [Phase 3]
A Phase 3 trial comparing albumin-bound interferon alfa-2b plus ribavirin versus pegylated interferon alfa-2a plus ribavirin in interferon-n…
-
CLINICAL_TRIALS trial_result · 2013-08-08Clinical Trial Update: Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3 [Phase 3]
Phase 3 clinical trial comparing albumin-bound interferon alfa-2b plus ribavirin to pegylated interferon alfa-2a plus ribavirin in interfero…
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Increasing Viral Testing in the Emergency Department [Phase 2, Phase 3]
Phase 2 and Phase 3 clinical trials evaluated increasing viral testing in the emergency department, focusing on HIV and Hepatitis C testing …
-
CLINICAL_TRIALS trial_result · 2013-08-06Clinical Trial Update: A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects [Phase 3]
A multicenter Phase 3 trial evaluated interferon-beta-1a for chronic hepatitis C in Asian subjects. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3 [Phase 2]
A Phase 2 clinical trial update reporting completion of a study evaluating Albuferon in combination with ribavirin for treatment-naive chron…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C [Phase 2]
A Phase 2 study evaluating albuferon in combination with ribavirin for interferon-treatment experienced chronic hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-01Clinical Trial Update: Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin [Phase 4]
A Phase 4 trial evaluating acetyl-L-carnitine supplementation during hepatitis C therapy (pegylated interferon-α2b plus ribavirin) has compl…
-
CLINICAL_TRIALS research · 2013-07-30Clinical Trial Update: Reasons for Non-treatment of Hepatitis C in HCV Mono-infected Patients Versus HCV-HIV Co-infected Patients in a University Setting
This study examined why patients with hepatitis C were not treated, comparing those with Hepatitis C alone to those co-infected with HIV in …
-
CLINICAL_TRIALS trial_result · 2013-07-26Clinical Trial Update: Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin: Effect on Work Performance. [Phase 3]
A phase 3 trial evaluating whether adding acetyl-L-carnitine to standard hepatitis C therapy with pegylated interferon alfa-2b plus ribaviri…
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy
The completed trial evaluated whether FGL2/Fibroleukin status can predict response to antiviral therapy in chronic hepatitis C virus infecti…